Clinical Trial Update: Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

View source ↗

Summary

This Clinical Trial Update describes a post-market clinical follow-up study of the CODMAN CERTAS Programmable Valve for hydrocephalus and related conditions; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Hemorrhagic Stroke
• Hydrocephalus
• Idiopathic Intracranial Hypertension
• Normal Pressure Hydrocephalus
• Post-traumatic Hydrocephalus

Drugs mentioned

• CODMAN CERTAS Programmable Valve

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Hydrocephalus, Hydrocephalus in Children | Status: ACTIVE_NOT_RECRUITING